IL87116A - 9-halogen-(z)-prostaglandin derivatives and pharmaceutical compositions containing the same - Google Patents

9-halogen-(z)-prostaglandin derivatives and pharmaceutical compositions containing the same

Info

Publication number
IL87116A
IL87116A IL87116A IL8711688A IL87116A IL 87116 A IL87116 A IL 87116A IL 87116 A IL87116 A IL 87116A IL 8711688 A IL8711688 A IL 8711688A IL 87116 A IL87116 A IL 87116A
Authority
IL
Israel
Prior art keywords
halogen
same
pharmaceutical compositions
compositions containing
prostaglandin derivatives
Prior art date
Application number
IL87116A
Other languages
English (en)
Other versions
IL87116A0 (en
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=25857817&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IL87116(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from DE19873724190 external-priority patent/DE3724190A1/de
Priority claimed from DE19873724189 external-priority patent/DE3724189A1/de
Application filed by Schering Ag filed Critical Schering Ag
Publication of IL87116A0 publication Critical patent/IL87116A0/xx
Publication of IL87116A publication Critical patent/IL87116A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00—Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • C07C405/0008—Analogues having the carboxyl group in the side-chains replaced by other functional groups
    • C07C405/0016—Analogues having the carboxyl group in the side-chains replaced by other functional groups containing only hydroxy, etherified or esterified hydroxy groups
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00—Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00—Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • C07C405/0008—Analogues having the carboxyl group in the side-chains replaced by other functional groups
    • C07C405/0025—Analogues having the carboxyl group in the side-chains replaced by other functional groups containing keto groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
IL87116A 1987-07-17 1988-07-15 9-halogen-(z)-prostaglandin derivatives and pharmaceutical compositions containing the same IL87116A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19873724190 DE3724190A1 (de) 1987-07-17 1987-07-17 9-halogen-3-oxa-(z)-(delta)(pfeil hoch)5(pfeil hoch)-prostaglandinderivate, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
DE19873724189 DE3724189A1 (de) 1987-07-17 1987-07-17 9-halogen-(z)-(delta)(pfeil hoch)4(pfeil hoch)-prostaglandinderivate, verfahren zu ihrer herstellung und ihrer verwendung als arzneimittel

Publications (2)

Publication Number Publication Date
IL87116A0 IL87116A0 (en) 1988-12-30
IL87116A true IL87116A (en) 1993-03-15

Family

ID=25857817

Family Applications (1)

Application Number Title Priority Date Filing Date
IL87116A IL87116A (en) 1987-07-17 1988-07-15 9-halogen-(z)-prostaglandin derivatives and pharmaceutical compositions containing the same

Country Status (12)

Country Link
US (1) US6225347B1 (es)
EP (1) EP0299914B2 (es)
JP (1) JP2716986B2 (es)
CA (1) CA1322197C (es)
DE (1) DE3880034D1 (es)
DK (1) DK170889B1 (es)
ES (1) ES2054860T5 (es)
HU (1) HU206084B (es)
IE (1) IE62483B1 (es)
IL (1) IL87116A (es)
NZ (1) NZ225436A (es)
WO (1) WO1989000559A1 (es)

Families Citing this family (50)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3923797A1 (de) * 1989-07-14 1991-01-24 Schering Ag 9-fluor-prostaglandin-derivate, verfahren zu ihrer herstellung und ihre pharmazeutische verwendung
DE4008925A1 (de) * 1990-03-16 1991-09-19 Schering Ag 9-halogenprostaglandin-clathrate und ihre verwendung als arzneimittel
DE4024347A1 (de) * 1990-07-27 1992-01-30 Schering Ag Cyclopentanderivate, verfahren zu ihrer herstellung und ihre pharmazeutische verwendung
DE4036140A1 (de) * 1990-11-09 1992-05-14 Schering Ag 9-halogen-11ss-hydroxy-prostaglandinderivate, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
KR100266834B1 (ko) * 1992-07-24 2000-09-15 우에하라 아끼라 프로스타글란딘 유도체
DE4229050A1 (de) * 1992-08-31 1994-03-03 Schering Ag Neue 9-Chlor-Prostaglandin-Ester und -amide
DE4229048A1 (de) * 1992-08-31 1994-03-03 Schering Ag Ester von 9-Chlor-Prostaglandinen, Verfahren zu ihrer Herstellung und ihre pharmazeutische Verwendung
DK0656889T3 (da) * 1992-08-31 1999-03-22 Schering Ag 9-chlorprostaglandinestere og -amider og deres anvendelse ved fremstilling af lægemidler
DE69311361T2 (de) * 1992-10-13 1998-01-08 Alcon Lab Inc Zusammensetzungen zur behandlung von glaukoma die prostaglandine und clonidinderivate enthalten
EP0666256A1 (en) * 1992-10-20 1995-08-09 Taisho Pharmaceutical Co. Ltd Prostaglandine derivative
US5721273A (en) 1993-12-15 1998-02-24 Alcon Laboratories, Inc. Use of certain 9-halo-13,14-dihydroprostaglandins to treat glaucoma and ocular hypertension
US5627209A (en) * 1993-12-15 1997-05-06 Alcon Laboratories, Inc. Use of certain 9-haloprostaglandins to treat glaucoma and ocular hypertension
AU687906B2 (en) * 1993-12-15 1998-03-05 Alcon Laboratories, Inc. Use of certain prostaglandin analogues to treat glaucoma and ocular hypertension
US5807892A (en) * 1994-09-30 1998-09-15 Alcon Laboratories, Inc. Use of certain prostaglandin analogues to treat glaucoma and ocular hypertension
US6294563B1 (en) 1994-10-27 2001-09-25 Allergan Sales, Inc. Combinations of prostaglandins and brimonidine or derivatives thereof
EP0861079A1 (en) * 1995-11-17 1998-09-02 Alcon Laboratories, Inc. Combination therapy for treating glaucoma
US6441047B2 (en) 1995-11-17 2002-08-27 Alcon Manufacturing Ltd.. Combination therapy for treating glaucoma
AU7680096A (en) * 1995-12-22 1997-07-17 Alcon Laboratories, Inc. Combinations of dp and fp type prostaglandins for lowering iop
US5700835A (en) * 1995-12-22 1997-12-23 Alcon Laboratories, Inc. 3-Oxa-D-prostaglandins for lowering IOP
US5599838A (en) * 1996-02-23 1997-02-04 Taisho Pharmaceutical Co., Ltd. Prostaglandin derivatives
EP0944593A2 (en) * 1996-11-12 1999-09-29 Alcon Laboratories, Inc. $i(CIS)-$g(D)?4 ANALOGS OF PROSTAGLANDINS AS OCULAR HYPOTENSIVES
US6015922A (en) * 1997-12-19 2000-01-18 Alcon Laboratories, Inc. N-alkyl-N-alkoxycarboxamides and methods of use in prostaglandin synthesis
US6740679B1 (en) * 1999-02-05 2004-05-25 Baylor University Medical Center Nutritional supplement or pharmaceutical preparation comprising triglycerides with seven-carbon fatty acid
US20030162833A1 (en) * 2001-08-01 2003-08-28 Roe Charles R. Fatty acid treatment for cardiac patients
CA2382265A1 (en) 1999-08-13 2001-02-22 Taisho Pharmaceutical Co., Ltd. Prostaglandin derivatives
KR100698433B1 (ko) * 1999-09-10 2007-03-22 사또, 후미에 프로스타글란딘 유도체
GB0012249D0 (en) * 2000-05-19 2000-07-12 Chirotech Technology Ltd Process for the preparation of 11-oxaprostaglandins
US20040266880A1 (en) * 2002-02-22 2004-12-30 Fumie Sato Antipruritics
MXPA04004371A (es) * 2002-08-09 2004-08-13 Taisho Pharmaceutical Co Ltd Agente antipruritico.
US7737182B2 (en) 2002-08-09 2010-06-15 Taisho Pharmaceutical Co., Ltd. Pharmaceuticals for xerosis
AU2003301900A1 (en) * 2002-11-13 2004-06-03 Fumie Sato Antipruritic drug
CA2784420C (en) 2004-07-02 2020-11-10 Baylor Research Institute Glycogen or polysaccharide storage disease treatment method
MY145694A (en) * 2005-04-11 2012-03-30 Xenon Pharmaceuticals Inc Spiroheterocyclic compounds and their uses as therapeutic agents
MY144968A (en) * 2005-04-11 2011-11-30 Xenon Pharmaceuticals Inc Spiro-oxindole compounds and their uses as therapeutic agents
SI1976828T1 (sl) 2005-12-29 2017-07-31 Celtaxsys, Inc. Diaminski derivati kot inhibitorji levkotrien A4 hidrolaze
US20110294842A9 (en) * 2006-10-12 2011-12-01 Xenon Pharmaceuticals Inc. Spiro (furo [3, 2-c] pyridine-3-3' -indol) -2' (1'h)-one derivatives and related compounds for the treatment of sodium-channel mediated diseases, such as pain
JP5460324B2 (ja) 2006-10-12 2014-04-02 ゼノン・ファーマシューティカルズ・インコーポレイテッド 治療剤としてのスピロ−オキシインドール化合物の使用
EP2350091B1 (en) * 2008-10-17 2015-06-03 Xenon Pharmaceuticals Inc. Spiro-oxindole compounds and their use as therapeutic agents
DK2350090T3 (en) * 2008-10-17 2015-09-07 Xenon Pharmaceuticals Inc Spiro-oxindole compounds and their use as therapeutic agents
AR077252A1 (es) * 2009-06-29 2011-08-10 Xenon Pharmaceuticals Inc Enantiomeros de compuestos de espirooxindol y sus usos como agentes terapeuticos
WO2011047173A2 (en) 2009-10-14 2011-04-21 Xenon Pharmaceuticals Inc. Pharmaceutical compositions for oral administration
WO2011047174A1 (en) 2009-10-14 2011-04-21 Xenon Pharmaceuticals Inc. Synthetic methods for spiro-oxindole compounds
US9504671B2 (en) 2010-02-26 2016-11-29 Xenon Pharmaceuticals Inc. Pharmaceutical compositions of spiro-oxindole compound for topical administration and their use as therapeutic agents
ES2714314T3 (es) 2012-04-12 2019-05-28 Xenon Pharmaceuticals Inc Síntesis asimétrica para compuestos de espiro-oxindol útiles como agentes terapéuticos
KR20150127245A (ko) 2013-03-14 2015-11-16 켈탁시스, 인코퍼레이티드 류코트라이엔 a4 가수분해효소의 저해제
US9682033B2 (en) 2015-02-05 2017-06-20 Teva Pharmaceuticals International Gmbh Methods of treating postherpetic neuralgia with a topical formulation of a spiro-oxindole compound
US10100060B2 (en) 2016-06-16 2018-10-16 Xenon Pharmaceuticals Inc. Asymmetric synthesis of funapide
US10385007B2 (en) 2016-12-09 2019-08-20 Celtaxsys, Inc. Monamine and monoamine derivatives as inhibitors of leukotriene A4 hydrolase
JP7145154B2 (ja) 2016-12-09 2022-09-30 セルタクシー、エルエルシー ロイコトリエンａ４ヒドロラーゼの阻害剤
WO2018107167A1 (en) 2016-12-09 2018-06-14 Celtaxsys, Inc. Pendant amines and derivatives as inhibitors of leukotriene a4 hydrolase

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE754114A (fr) 1969-07-29 1971-01-29 Upjohn Co Nouveaux composes de la classe des prostaglandines et leur procede de preparation
US3936487A (en) 1970-06-17 1976-02-03 The Upjohn Company 3-Oxa prostaglandin Fα-type compounds
US3954835A (en) 1972-04-27 1976-05-04 The Upjohn Company 4,5-Cis-didehydro-PGF1 compounds
US3980694A (en) 1974-04-11 1976-09-14 The Upjohn Company 4-Oxa phenyl-substituted PGA compounds
DE2845770A1 (de) 1978-10-19 1980-04-30 Schering Ag Neue prostacyclin-derivate und verfahren zu ihrer herstellung
DE2950027A1 (de) 1979-12-10 1981-06-11 Schering Ag Berlin Und Bergkamen, 1000 Berlin 9-chlor-prostaglandinderivate, verfahren zur herstellung und verwendung als arzneimittel
DE3048906A1 (de) 1980-12-19 1982-07-15 Schering Ag, 1000 Berlin Und 4619 Bergkamen Neue carbacycline, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
DE3126924A1 (de) * 1981-07-03 1983-01-20 Schering Ag, 1000 Berlin Und 4619 Bergkamen 9-fluor-prostaglandinderivate, verfahren zur herstellung und verwendung als arzneimittel
US4579958A (en) 1983-12-23 1986-04-01 G. D. Searle & Co. 5-fluoro-3-oxa-6,7-didehydro-PGI1 compounds
US4971987A (en) * 1984-07-27 1990-11-20 Schering Aktiengesellschaft New carbacycline, process for their production and their use as a drug
DE3510978A1 (de) * 1985-03-22 1986-09-25 Schering AG, Berlin und Bergkamen, 1000 Berlin Neue 9-halogenprostaglandine, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
KR100266834B1 (ko) 1992-07-24 2000-09-15 우에하라 아끼라 프로스타글란딘 유도체

Also Published As

Publication number Publication date
EP0299914B2 (de) 2003-04-23
JPH02502009A (ja) 1990-07-05
EP0299914A1 (de) 1989-01-18
HU206084B (en) 1992-08-28
IE62483B1 (en) 1995-02-08
WO1989000559A1 (en) 1989-01-26
IL87116A0 (en) 1988-12-30
DE3880034D1 (de) 1993-05-13
EP0299914B1 (de) 1993-04-07
HUT51222A (en) 1990-04-28
JP2716986B2 (ja) 1998-02-18
DK132789D0 (da) 1989-03-17
IE882189L (en) 1989-01-17
DK170889B1 (da) 1996-03-04
ES2054860T3 (es) 1994-08-16
ES2054860T5 (es) 2003-11-01
DK132789A (da) 1989-03-17
CA1322197C (en) 1993-09-14
US6225347B1 (en) 2001-05-01
NZ225436A (en) 1991-04-26

Similar Documents

Publication Publication Date Title
IL87116A (en) 9-halogen-(z)-prostaglandin derivatives and pharmaceutical compositions containing the same
PH25932A (en) Adenosine derivatives and pharmaceutical compositions containing the same
IL88988A0 (en) Didehydro-vitamin d3 derivatives and pharmaceutical compositions containing them
GB2222772B (en) Pharmaceutical compositions
NZ220880A (en) Di-tert-butyl-phenol derivatives and pharmaceutical compositions
GB2219940B (en) Pharmaceutical compositions
IL72566A (en) Androst-5-en-17-one and 5alpha-androstan-17-one derivatives and pharmaceutical compositions containing the same
NZ221996A (en) Imidazo-pyridine derivatives and pharmaceutical compositions
NZ220171A (en) Dihydro-benzopyran derivatives and pharmaceutical compositions
NZ226002A (en) Peptidylheterocyclic compounds and pharmaceutical compositions
NZ226481A (en) Dideoxycytidine derivatives and pharmaceutical compositions
PH21540A (en) Cholecalciferol derivatives and pharmaceutical compositions containing the same
AU8316587A (en) Pharmaceutical compositions and their use
NZ226450A (en) Crystalline-1-carbacephalosporin and pharmaceutical compositions
IL89502A0 (en) Plantinum derivatives and pharmaceutical compositions containing the same
IL86081A0 (en) Benzazepine derivatives and pharmaceutical compositions containing the same
NZ225613A (en) Benzazepin-2-one derivatives and pharmaceutical compositions
NZ208694A (en) Rooperol derivatives and pharmaceutical compositions
IL80668A0 (en) Benzazepine derivatives and pharmaceutical compositions containing the same
IL87494A0 (en) Pharmaceutical compositions containing benzylpyrimidine derivatives
NZ226738A (en) Ginkgolide derivatives and pharmaceutical compositions
PH24950A (en) Pyrrolidine derivatives and pharmaceutical compositions containing the same
PH19575A (en) Cephalosporing derivatives and pharmaceutical compositions thereof
NZ223051A (en) Carbamoyloxylabdane derivatives and pharmaceutical compositions
NZ207806A (en) Benzothienyl-cephalosporin derivatives and pharmaceutical compositions

Legal Events

Date Code Title Description
KB Patent renewed
KB Patent renewed
MM9K Patent not in force due to non-payment of renewal fees